South State Corp Novo Cure LTD Transaction History
South State Corp
- $2.14 Billion
- Q1 2025
A detailed history of South State Corp transactions in Novo Cure LTD stock. As of the latest transaction made, South State Corp holds 56 shares of NVCR stock, worth $1,070. This represents 0.0% of its overall portfolio holdings.
Number of Shares
56Holding current value
$1,070% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NVCR
# of Institutions
266Shares Held
79.4MCall Options Held
970KPut Options Held
118K-
Black Rock Inc. New York, NY12.1MShares$232 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.3MShares$215 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA8.95MShares$171 Million0.03% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT5.52MShares$106 Million8.14% of portfolio
-
Capital World Investors Los Angeles, CA5.22MShares$99.7 Million0.02% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $2.01B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...